Innate Pharma SA 20-F for FY2024
Innate Pharma SA (IPHA)
20-F
2025-04-30
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 20-F
Innate Pharma SA filed this 20-F on April 30, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 20.12M EUR
- down 67.4% from 61.64M EUR a year earlier
- Net loss
- 49.47M EUR
- compared with a net loss of 7.57M EUR a year earlier
- Diluted EPS
- -0.61 EUR
- compared with -0.09 EUR a year earlier